/Investor DB

Threshold Ventures — 2023 Investments

5 investments dated 2023 · listed companies and verified rows first · show all

CloudZerocloudzero.comin𝕏Series B · Jun 2023 · $32M

CloudZero provides cost allocation and financial management for AI workloads, helping companies understand the ROI of their AI investments across cloud platforms and AI services.

AI & Machine LearningCloud ComputingEnterprise SoftwareBoston, US

Erik Peterson(Founder)inMatt Manger(Founder)inPhil Pergola(Executive Officer, Director)inDon Bulens(Executive Officer, Director)

BoardJames Orsillo(Director)inTim Barrows(Director)

Co-investorsG20 VenturesInnovius CapitalMatrixUnderscore VC

Inscribeinscribe.aiin𝕏Series B · Jan 2023 · $25M

Inscribe builds an AI-powered document fraud detection platform for financial institutions, banks, and fintechs to identify and prevent fraudulent applications.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSan Francisco, US

Ronan Burke(CEO)inConor Burke(CTO)inDarragh Mc Kay(Full Stack Software Engineer)inOisín Moran(Engineering Manager)Anisha Thomas(Head of People)Ryan Gross(Head of Sales)

Co-investorsCrosslink CapitalFoundryGaingelsJuvo VenturesUncork CapitalY Combinator+7 more

Odaiaodaia.aiinSeries B · May 2023 · $34M

ODAIA offers Marketing Intelligence, a platform for pharmaceutical marketing and sales teams that ties channel-level actions to prescription (Rx) outcomes and coordinates healthcare provider (HCP) engagement across digital and field channels.

AI & Machine LearningDigital HealthHealthtechMarketing TechSaaSSales Tech

Philip Poulidis(Founder)inHelen Kontozopoulos(Founder)

Co-investorsAlumni VenturesGraphite VenturesMonograph Capital PartnersPanache VenturesStand Up VenturesToronto Innovation Acceleration Partners+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Aiwa Health, Inc.Morphoses

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.